Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 687K in Stock for its fiscal semester ending in December of 2023. Data for AS Company | ASCO - Stock including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR48.57M in Market Capitalization this June of 2025, considering the latest stock price and the number of outstanding shares.Data for AS Company | ASCO - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 13.13M in Outstanding Shares in January of 2025. Data for AS Company | ASCO - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 0.21 in EPS Earnings Per Share for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR38.88M in Current Assets for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Current Assets including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR16.45M in Operating Expenses for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Operating Expenses including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR811.9K in Debt for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Debt including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR2.71M in Net Income for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Net Income including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR1.62M in EBIT for its fiscal semester ending in June of 2023. Data for AS Company | ASCO - Ebit including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR48.82M in Assets for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Assets including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 79 in Employees for its fiscal semester ending in December of 2023. Data for AS Company | ASCO - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR3.37M in EBITDA for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Ebitda including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 8.28 in PE Price to Earnings for its fiscal semester ending in June of 2024. Data for AS Company | ASCO - PE Price to Earnings including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR10.33M in Cost of Sales for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR5.5M in Selling and Administration Expenses for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Selling And Administration Expenses including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR8.4M in Current Liabilities for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR8.66M in Ordinary Share Capital for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last June in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR3.71M in Cash and Equivalent for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Cash And Equivalent including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 4.93 in Dividend Yield for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Dividend Yield including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported EUR650.29K in Loan Capital for its fiscal semester ending in December of 2024. Data for AS Company | ASCO - Loan Capital including historical, tables and charts were last updated by Trading Economics this last July in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
AS Company reported 687K in Stock for its fiscal semester ending in December of 2023. Data for AS Company | ASCO - Stock including historical, tables and charts were last updated by Trading Economics this last July in 2025.